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Abstract
The hypothalamic melanocortin system—the melanocortin receptor of type 4 (MC4R) and its ligands: a-melanin-stimulating
hormone (a-MSH, agonist, inducing hypophagia), and agouti-related protein (AgRP, antagonist, inducing hyperphagia)—is
considered to play a central role in the control of food intake. We tested its implication in the mediation of the hunger-
curbing effects of protein-enriched diets (PED) in mice. Whereas there was a 20% decrease in food intake in mice fed on the
PED, compared to mice fed on an isocaloric starch-enriched diet, there was a paradoxical decrease in expression of the
hypothalamic proopiomelanocortin gene, precursor of a-MSH, and increase in expression of the gene encoding AgRP. The
hypophagia effect of PED took place in mice with invalidation of either MC4R or POMC, and was even strengthened in mice
with ablation of the AgRP-expressing neurons. These data strongly suggest that the hypothalamic melanocortin system
does not mediate the hunger-curbing effects induced by changes in the macronutrient composition of food. Rather, the
role of this system might be to defend the body against the variations in food intake generated by the nutritional
environment.
Citation: Pillot B, Duraffourd C, Be´geot M, Joly A, Luquet S, et al. (2011) Role of Hypothalamic Melanocortin System in Adaptation of Food Intake to Food Protein
Increase in Mice. PLoS ONE 6(4): e19107. doi:10.1371/journal.pone.0019107
Editor: Carlo Polidori, University of Camerino, Italy
Received February 10, 2011; Accepted March 16, 2011; Published April 22, 2011
Copyright:  2011 Pillot et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: Work was supported by funding from CNRS and INSERM. Bruno Pillot has been supported by a grant from the « Socie´te´ Franc¸aise de Nutrition ». The
funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: gilles.mithieux@inserm.fr
Introduction
The worldwide expression of obesity and type 2 diabetes makes
more and more intriguing a better understanding of the
mechanisms regulating food intake [1,2]. The brain, more
particularly the hypothalamus, plays a central role in this control.
The hypothalamus integrates circulating signals of hunger and
satiety together with nutrient-derived signals that reflect the
availably of energy stores of the body. This allows the brain to
adapt energy intake and energy expenditure to the actual
requirement of the body [3].
Indeed, insulin or leptin, two major hunger-suppressing
hormones, are able to cross the blood brain barrier at the level
of the hypothalamus and surfeit energy intake by generating
anorectic signaling upon binding to their receptor expressed in
neurons of the arcuate nucleus [1,3,4]. Conversely, ghrelin has a
positive action on food intake that is mediated, at least in part, via
the binding to ghrelin receptor located on arcuate neurons [5,6].
In addition, a number of gastrointestinal hormones, released after
the meal, have the capacity to promote satiation and/or satiety.
Cholecystokinin, glucagon-like peptide 1 or PYY belong to these
gastrointestinal hormones capable of decreasing hunger [7,8,9].
Regarding these hormones, experiments of vagotomy have
strongly suggested that they could be sensed peripherally, and
transmitted to the brain via the gastrointestinal nervous system
[9,10,11,12]. However, in all cases, the hypothalamus constitutes
the ultimate site of integration of both centrally- and peripherally-
mediated hormonal mechanisms of control of food intake [1,2,3].
Within the hypothalamus, the melanocortin system is a
hormone-receptor system that plays a crucial role to translate
the sensing of hunger-modulating hormones into changes in the
sensation of hunger and satiety. MC receptors are widely
expressed throughout the hypothalamus [13,14] and, among the
MC receptors, the MC3R and MC4R are particularly involved in
energy balance regulation. a-melanocortin-stimulating hormone
(a-MSH), a postranslational product of the Pro-opiomelanocortin
(POMC) gene, binds to the MC receptor on key structures in the
central nervous system and triggers an anorectic signal [15].
POMC gene is expressed in neurons located in the arcuate
nucleus. In parallel, other neurons of the arcuate nucleus express
the neuropeptide Y (NPY) and the agouti-related protein (AgRP),
an inverse agonist of MCR that prevents a-MSH binding onto
MC3R and MC4R. Consequently, these neurons activate hunger
by suppressing the a-MSH action. That the melanocortin system
(MCS) is central in the control of the sensation of hunger and
satiety has been ascertained from genetic studies in humans and
mice. Hence, MC4R-Ko mice rapidly develop a dramatic obese
phenotype consecutive to hyperphagia [16], while mutations in the
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MC4R gene have been associated to morbid obesity in humans
[17]. Moreover, transgenic mice over-expressing AgRP develop
early hyperphagia and obesity [18].
Whereas the peripheral and central control of food intake has
been widely studied, the central mechanism that modulates the
response to food quality and composition are scarce. A better
knowledge of this mechanism, however, could provide a rationale
for nutritional manipulation as a potential strategy to prevent and
to treat obesity and diabetes. Indeed, the composition of the diet
may be deleterious, causing obesity and insulin resistance, which is
the case for western diets rich in lipids and in sweet [19,20]. On
the contrary, it could be beneficial, which is the case for protein-
enriched diets (PED), initiating satiety phenomena [21,22] and
amelioration of glucose control in type 2 diabetic patients [23].
The MCS stands as a likely candidate to mediate the behavioral,
hormonal and metabolic consequences of nutritional manipulation
[24]. However, in a previous study pertaining to the regulation of
the expression of the hypothalamic MCS by a high fat-diet, we
unexpectedly observed an increase in the POMC to AgRP ratio,
whilst mice fed this type of regimen exhibited hyperphagia and
obesity [25]. This has suggested that the MCS might combat,
rather than mediate, the changes in food intake induced by the
diet. However, the interpretation of the data from high-fat diets is
not unequivocal. Whereas the animals increased their intake in
terms of calories ingested, they slightly decreased it in terms of
weight of food ingested (due to the high caloric density of HF-HS
diet compared to control chow).
To better understand the role of the MCS in mediating the
effect of diet composition and quality onto energy balance, we
have dissected out the implication of several cellular and molecular
components of the MC system in the control of food intake by
nutrients. We studied here the changes in MCS-related gene
expression, body weight and food intake initiated by a high-
protein (HP) diet. The diet used was balanced for increased
proportion of protein by decreasing the carbohydrate content.
Caloric density was thus identical to control chow diet.
Furthermore, to question the causal role of the MCS, we studied
the effect of HP diet in mice with deletion of the components of the
system.
Materials and Methods
Animals
Wild-type mice. Two mouse strains were used as control:
C57Bl/6 and 129Sv. For each strain, four weeks-old male mice
were purchased from Harlan (Gannat, France) and housed at
21uC with normal light/dark cycle and free access to water and
food. After one week acclimatization and feeding with A04
standard chow from SAFE (Augy, France), mice were randomized
and divided in two groups, with free access to either starch-
enriched diet (SED: 16% protein from soybean and fish, 55%
starch glucose, 5% lipids, 6% mineral salts, 5% cellulose, 1%
vitamins, 12% water, by weight) or a protein-enriched diet (PED:
54% protein from casein-soybean, 17% starch glucose, 5% lipids,
6% mineral salts, 5% cellulose, 1% vitamins, 12% water) from
SAFE. Body weight and food intake were continuously recorded.
Gene invalidated mice. Two different knock-out mouse
models were used. The first model, obtained from Jackson
Laboratories (Bar Harbour, Maine, USA), was the loxTBMC4r
mice developed by Balthasar et al. [26], that do not express MC4R
and display morbid obesity. They were bred on a mixed C57Bl/6
and 129Sv background. The second model, POMC-deficient, was
developed on a 129SV background by Challis et al. [27] and was
obtained directly from this laboratory. As the homozygous
POMC2/2 mice are deprived of all POMC-derived peptides,
they must be supplied with corticosterone-supplemented drinking
water (25 mg/mL final concentration). Heterozygous mice were
mated and female mice were supplied with corticosterone during
the last week of gestation and the whole lactation period.
Homozygous mice were supplied with corticosterone from
weaning and during the whole experiment. Those transgenic 5-
week old mice were also divided in two groups fed either with SED
or the same PED than wild-type mice. Food intake and body
weight were recorded as for wild-type mice.
Production of mice lacking NPY/AgRP neurons.
Heterozygous AgrpDTR/+ mice with the human diphtheria toxin
receptor (heparin-binding epidermal growth factor) targeted to
Agrp locus have been described [28,29]. Briefly, a cassette
containing the human DTR open reading frame was placed
upstream of the initiation codon of Agrp in the first exon.
AgrpDTR/+ express, therefore, the hDTR onto NPY/AgRP
neurons, which allows the specific depletion of NPY/AgRP
neurons by peripheral injection of DT toxin. For the
experiments, homozygous AgrpDTR/DTR males (on mixed 129/
Sv6C57Bl/6 genetic background) were bred with C57Bl/6 wild-
type, female Agrp+/+ mice, such that all the offspring would be
AgrpDTR/+ heterozygotes. Litters born at the same time were
either injected within 2–5 days after birth with DT (75 ng in 20 ml
saline) or untreated (naı¨ve). Mice were housed at 20–22uC with a
12 hr light/12 hr dark cycle and provided with standard mouse
chow diet (A03 Safe diets 3,2 Kcal/g), unless otherwise indicated.
The extent of NPY/AgRP neurons depletion was assessed by the
lack of orexigenic response to peripherally injected ghrelin in mice
lacking NPY/AgRP neurons. Prior to the feeding experiment the
groups ‘‘naı¨ve’’ and ‘‘treated’’ were individually housed at least 2
months prior to the experiment. During food intake
measurements, body weight and food intake were monitored
daily, then mice were switched to a PED, and maintained on this
diet for 6 days. By the end of the 6 days, mice were switched back
to SED.
All animal care and experimental procedures were approved by
the animal ethics committee of the university of Lyon.
Real-time quantitative RT-PCR analysis
After 4 days of SED or PED, respectively, 5 weeks-oldC57Bl/6
mice were killed by cervical dislocation after a 6-hour fasting
period. Brain was removed. The whole hypothalamus was rapidly
dissected out and frozen in liquid nitrogen. The limits of the
hypothalamus for dissection were the optic chiasma at the anterior
border, the mammillary bodies at the posterior border and, on
both lateral sides, the hypothalamic sulci. The tissue was finally cut
dorsally at 2 mm from the ventral face.Total RNA was extracted
with the TRIzol Reagent (Invitrogen). The level of target mRNAs
was measured by RT followed by real-time PCR. First-strand
cDNAs were synthesised from 500 ng total RNA using M-MLV
reverse transcriptase RNAse H minus (Promega, France) and
oligo(dT) primers. PCR was realized with Master SYBR Green 1
Mixture (Roche Diagnostics, Germany) with specific primers : 59-
TCTCTATGTCCACATGTTCCTG-39 (sens) and 59-GGGGC-
CCAGCAGACAACAAAG-39 (non sense) for MC4-R, 59-CTCA-
AGAAGACAACTGCAGAC-39 (sense) and 59-TGAAGAAGC-
GGCAGTAGCAC-39 (non sense) for AgRP, 59-ATGCCGA-
GATTCTGCTACAGTCG-39 (sense) and 59-TTCATCTC-
CGTTGCCAGGAAACAC-39 (non sense) for POMC and 59-
TTCCAGTATGACTCCACTCACG-39 (sense) and 59-AGACT-
CCACGACATACTCAGCA-39 (non sense) for GAPDH. Quan-
titative PCR is realized using a light-cycler (Roche Diagnostics,
Germany). A standard curve was systematically generated with
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different amounts of purified target cDNA, and each assay was
performed in duplicate. GAPDH transcript was used as a reference
and results are expressed by a ratio relative to GAPDH expression.
Plasma hormone measurements
Plasma insulin and leptin concentrations were determined using
commercially available assay kits (from Crystalchem, Chicago,
USA and AbCys, PAris, France, respectively).
Results and Discussion
It is well established that regimens enriched in protein decrease
hunger sensations and subsequent food consumption in rats and
humans [21,22,30,31,32]. In rats, after a transient period of some
days of habituation to the HP food, the steady daily food intake was
blunted by about 20% for the next two weeks [33]. When C57B6/J
mice were given a HP diet, they markedly decreased their food intake
the 2 first days (by about 40%). Then, they re-increased their food
intake to about 80% of their previous intake with the iso-caloric chow
diet (fig. 1A). This was comparable to the rat response to the HP diet
[33]. As a consequence of diminished food intake, C57B6/j mice
attenuated their growth rate upon HP diet, exhibiting a transient
decrease in body weight followed by a phase of stabilization (Fig. 1B).
Next, we analyzed the hypothalamic content of mRNAs
encoding the MC4R, POMC and AgRP in mice fed on the HP
diet, compared to their counterparts fed on the standard chow
Figure 1. Effect of PEDon food intake and bodyweight in C57bl6J andMC4-R KOmice. Food intake (panels A,C) and body weight (B,D) were
measured in control mice (circles) and in MC4R-KO mice (squares), fed either on a starch enriched diet (SED, open forms) or on a protein enriched diet
(PED, filled forms). PED was first given from ‘‘day 0’’, mice being previously fed on the SED. For each point determination, n = 8 mice were studied. The
data are expressed as means+/2SEM. The results have been reported to a reference value, calculated as the average of 3 prior consecutive days of SED
(from days 26 to 24). The results are expressed as % of this reference. 100% represented 0.5 and 0.73 cal/d/g body weight in C57bl6J and MC4-R KO
mice, respectively. All data from day 1 are different from day 0 for PED feeding (p,0.05, Student’s t test for paired data), in both panel A and C.
doi:10.1371/journal.pone.0019107.g001
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diet. There was no difference induced by the PED in the MC4R
mRNA content (Fig. 2) whereas there was a marked decrease in
the POMC mRNA content, by about 2.3 times (Fig. 2), and a
marked 2.5 fold increase in the AgRP mRNA content (Fig. 2). This
represented an increase by about 7 times of the AgRP to POMC
ratio. In the same time, the animals were hypophagic. The
analyses reported in Fig. 2 were performed after 4 days of protein
regimen. One could argue that the AgRP to POMC expression
change could be representative of an early phenomenon, aimed at
compensating the early suppression of food intake consecutive to
the switch on a novel diet. Therefore, we performed comparable
analyses by 12 and 30 days after the switch on the protein diet, i.e.
at a time of steady food intake. The results were comparable,
revealing increases in AgRP and decreases in POMC expression
(data not shown). There was, however, an attenuation of the
changes with regards to the situation at 4 days, since the ratio of
AgRP to POMC was increased by 3.3 times and 2.4 times, at 12
and 30 days after switching on the protein diet, respectively (results
from 9 rats per group at each time, p,0.001 in each case). To
question whether these changes could be related to a change in the
hormonal status, we assayed plasma insulin and leptin after
switching on the PED. There was no change in either plasma
insulin or leptin under conditions of steady food intake, after the
switch on PED: insulin: 0.82+/20.12 vs 0.87+/20.18 ng/mL in
SED- and PED-fed mice, respectively (NS); leptin: 0.77 +/20.23
vs 0.66+/20.21 ng/mL in SED- and PED-fed mice, respectively
(NS).
These data strongly suggested that protein-induced hypophagia
was not mediated by an enhanced activity of the MCS, but rather
support the hypothesis according to which a decreased MCS tonus
is actively triggered to counteract the hypophagia effect, in order
to maintaining the former food intake. Interestingly, this inference
is in keeping with previous data from our group, and others, that
illustrated a negative action of high-fat diets onto AgRP mRNA
expression and the AgRP/POMC ratio, with a concomitant
hyperphagia [25,28,29]. These previous data were not unequiv-
ocal, however, because of the high caloric density of HF diets (see
introduction). Moreover, as previously acknowledged (Gout et al,
2008), other studies reported opposite results, which has suggested
that the changes in AgRP/POMC could at least in part depend on
physiological conditions related to the mouse strain, age, or time
on the HF diet. We provide here stronger arguments in support of
the aforementioned hypothesis. Indeed, because the HP diet and
the control diet exhibited similar caloric densities, the changes in
food intake were similar, that they were expressed as calories
ingested by g of body weight per day, or as g of food ingested/g/
day. It is noteworthy that the HP-initiated changes were specific of
AgRP and POMC. There was no significant change in the
expression of NPY (an orexigenic neuropeptide co-expressed with
AgRP), induced by protein dieting (data not shown). We also
analyzed the mRNA levels of some orexigenic neuropeptides
expressed in the lateral hypothalamus: hypocretin (Hcrt) and pro-
melanin-concentration hormone (Pmch, i.e. the precursor of
melanin-concentrating hormone). There was no alteration in the
mRNA levels of either neuropeptide induced by the protein diet
(data not shown).
To question more in depth the role of the MCS in the changes
in food intake initiated by food quality changes, we studied the
effect of HP diet in mice with deletion of the components of the
MCS. MC4R-KO mice, backcrossed on a C57B6/J genetic
background, like C57B6/J control mice, depressed their food
intake when switched in the HP diet (Fig. 1C). The further
evolution of food intake was very comparable to that in control
mice. Similarly, there was a marked attenuation of their growth
rate upon HP dieting (Fig. 1D). This strongly suggested that
MC4R was not mandatory for the hypophagia effect induced by
nutritional protein. Next, we questioned the effect of HP diet in
mice with deletion of the POMC gene. Because these mice were
backcrossed on a 129SV genetic background, and required a
corticosterone treatment to prevent any deficiency in the
corticotrope axis, we studied in parallel the effect of the HP diet
in control 129SV treated with the same daily dose of corticoste-
rone. Whereas the initial blunting of food intake upon switching
on the HP diet was less marked than in the C57B6/J background,
the steady state suppression of food intake about 220%) was very
similar in both the control and the POMC-KO mice (Fig. 3A and
C). In line with the suppression of food intake, there was a
comparable attenuation of the growth rate of 129SV and POMC-
KO mice upon feeding on the HP diet (Fig. 3B and D). This result
strongly suggested that the POMC gene, precursor of a-MSH, was
not essential for the hunger-suppressing effect of food protein diet.
Lastly, we studied the effect of the HP diet in mice with deletion of
the arcuate NPY/AgRP neurons. The strategy of deletion involves
the expression of the receptor to the diphtheria toxin under the
control of the AgRP gene promoter. Heterozygous AgRPDTR/+
mice were treated (AgRPDTR/+-injected), or not (AgRPDTR/+-
naive), a few days after birth with the diphtheria toxin. Under
these conditions of early deletion of the NPY/AgRP-expressing
Figure 2. Hypothalamic contents in MC4-R, POMC and AgRPmRNAs. Determinations by quantitative RT-PCR. The relative mRNA contents
were measured in hypothalamus of five-weeks-old C57bl6J mice after 4 days of diet of PED compared to SED fed mice, and reported to a GAPDH
mRNA as a standard. *, p,0,05 (t test for unpaired samples).
doi:10.1371/journal.pone.0019107.g002
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neurons, AgRPDTR/+-injected mice further exhibited a normal
food intake under standard chow diet, as previously described
[34,35]. Upon switching onto protein diet, there was an early drop
in food intake in AgRPDTR/+-naive followed by a progressive
return to a food intake minored by about 20% (Fig. 4A). This drop
was very similar to that observed in C57B6/J mice (compare with
Fig. 1A). Interestingly, the drop observed in AgRPDTR/+-injected
mice was significantly stronger than that in their littermates. It is
noteworthy that such a difference was not observed in the changes
in food intake promoted by protein diet in either MC4R2/2 or
POMC2/2 mice, compared to their respective controls (see Fig. 1
and Fig. 3). Because these mice continuously lost weight, we
stopped PED feeding to switch back on standard chow, when
weight loss was beyond 20% of their starting body weight (Fig. 4B).
These data suggest again that specific inhibition of NPY/AgRP
neurons was not mandatory for the hypophagia induced by
nutritional protein. Moreover, because the hypophagia effect
appeared stronger in mice lacking the NPY/AgRP than in
controls, this might suggest that NPY/AgRP-expressing neurons
are important in a defense process to maintaining food intake and
body weight during the hypophagic phase initiated by protein diet.
This is in line with the fact that hypothalamic AgRP content and
AgRP to POMC increased ratio is a key feature associated to the
hypophagic response to protein feeding in the normal situation
(results of Fig. 2). This observation, thus, further support our
hypothesis. It must be noted that AgRP is still able to enhance food
Figure 3. Effect of PED on food intake and body weight in SV129 and POMC KO mice. Food intake (A, C) and body weight (B, D) were
measured in wild-type mice (circles) and in POMC-KO mice (squares), fed either on a starch enriched diet (SED, open forms) or on a protein enriched
diet (PED, filled forms). Expression and presentation of data are as described in the legend of Fig. 1 (n = 8 mice studied). 100% represented 0.63 and
0.69 cal/d/g body weight in 129SV and POMC KO mice, respectively. All data from day 1 are different from day 0 for PED feeding (Student’s t test for
paired data), in both panel A and C.
doi:10.1371/journal.pone.0019107.g003
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intake in mice invalidated for both MC3R and MC4R, which has
suggested that AgRP could have an effect independent of its
antagonist role towards both MCRs (see [36] for a recent review).
Thus, the hypothesis that AgRP might interfere in mechanisms
independent of MC3R and MC4R constitutes an additional
attractive rationale.
Taken together, the data presented herein strongly suggest that
activation of the satiety MCS is not mandatory for the inhibition of
food intake induced by protein diet. This comes in discrepancy
with the compelling body of arguments which have established
that hypothalamic MCS is one of the main anorectic signals,
through which most satiety actions are believed to occur [3,37]. It
is noteworthy to recall here that there is no change in plasma
insulin or leptin concentrations, which could account for the
AgRP/POMC changes observed on protein-diet (see above).
Moreover, our results also suggest that inhibition of a-MSH-
induced satiety signals is a likely mechanism involved to defend
food intake and body weight against variations in hunger initiated
by environmental nutritional changes, such as the variable
availability in different sources of macronutrients. In conclusion,
even if the changes in hunger and satiety depending on nutrients
remain to be fully understood, the present study adds a significant
piece in the understanding of the central mechanisms of control of
energy homeostasis.
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